Abbott is a diversified healthcare company operating across diagnostics, medical devices, nutrition, and biowearables with 115,000 employees serving more than 160 countries. The organization spans multiple technical domains: continuous glucose monitoring systems, implantable cardiovascular devices including leadless pacemakers, wearable health sensors, diagnostic testing platforms, and nutritional science products. With roots in 1888, the company has maintained sustained focus on device and diagnostic engineering across decades.
In continuous glucose monitoring, Abbott manufactures FreeStyle Libre, a wearable system for diabetes management. In cardiovascular implants, the company produces the AVEIR DR, a leadless pacemaker design that eliminates transvenous leads - a structural simplification that reduces implantation complexity and associated risks. The Lingo platform represents their entry into consumer biowearables for metabolic monitoring. On the diagnostics side, Abbott has pioneered work in infectious disease testing, including early HIV blood test development.
The engineering and product challenges span both hardware and firmware domains. Implantable devices require hermetic packaging, wireless power and telemetry systems operating under FCC constraints, and biocompatibility validation. Wearable sensors demand miniaturization, battery efficiency, and algorithmic signal processing for physiological measurement. Diagnostic systems integrate fluidics, optical sensing, and immunoassay chemistry at manufacturing scale. These products operate in regulated markets requiring clinical validation and post-market surveillance infrastructure.